Search company, investor...

Protein Sciences

Founded Year



Acquired | Acquired

Total Raised




About Protein Sciences

Protein Sciences specializes in vaccine development and protein production.

Headquarters Location

1000 Research Parkway

Meriden, Connecticut, 06450,

United States

(800) 488-7099

Missing: Protein Sciences's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Protein Sciences's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Protein Sciences Patents

Protein Sciences has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Molecular biology, Monoclonal antibodies, Biotechnology, Immunology, Viral plant pathogens and diseases


Application Date


Grant Date



Related Topics

Molecular biology, Monoclonal antibodies, Biotechnology, Immunology, Viral plant pathogens and diseases



Latest Protein Sciences News


Dec 21, 2021

BIO-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT, PROTEIN SCIENCES SEGMENT MINNEAPOLIS, Dec. 21, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced William A. Author: MINNEAPOLIS, Dec. 21, 2021 /PRNewswire/ -- Bio-Techne Corporation ( TECH ) - Get Bio-Techne Corporation Report today announced William A. Geist has been appointed President, Protein Sciences Segment, effective January 3, 2022. Mr. Geist succeeds N. David Eansor, who will be retiring from the Company. Mr. Eansor will remain with Bio-Techne through the end of February 2022 to ensure a smooth transition. Mr. Geist has over two decades of experience as a senior life science tools leader, most recently serving as Chief Operating Officer for Quanterix, where he was responsible for enterprise-wide operations and strategy deployment. Previously Mr. Geist was Vice President & General Manager for two of Thermo Fisher Scientific's largest Business Units, Protein & Cell Analysis and qPCR. Prior to Thermo Fisher Scientific, Mr. Geist was Vice President of QuantaBiosciences, a QIAGEN company, where he held various roles of increasing responsibility from the company's inception through its acquisition. "I want to personally thank Dave for his leadership and significant contributions over the last seven years at Bio-Techne. He has played an integral role in the Company's success, and I wish him the best in his retirement," said Chuck Kummeth, President and Chief Executive of Bio-Techne. "Will is joining Bio-Techne at a very exciting point in the Company's growth trajectory. His experience running life science tools businesses generating over $1 billion in annual revenue make him the ideal candidate to take the Protein Sciences Segment through its next phase of growth."

Protein Sciences Frequently Asked Questions (FAQ)

  • When was Protein Sciences founded?

    Protein Sciences was founded in 1983.

  • Where is Protein Sciences's headquarters?

    Protein Sciences's headquarters is located at 1000 Research Parkway, Meriden.

  • What is Protein Sciences's latest funding round?

    Protein Sciences's latest funding round is Acquired.

  • How much did Protein Sciences raise?

    Protein Sciences raised a total of $3.5M.

  • Who are the investors of Protein Sciences?

    Investors of Protein Sciences include Sanofi, Pacific Venture Group, Ropart Asset Management Funds, Diamyd Medical and Emergent BioSolutions.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.